Evidence map›Paper›PMID 29732714›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2018

Brief Report: Whole-Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African Americans.

Pravitt Gourh, Elaine F Remmers, Steven E Boyden, Theresa Alexander, Nadia D Morgan, Ami A Shah, Maureen D Mayes, Ayo Doumatey, Amy R Bentley, Daniel Shriner and 32 more

Open access · bronzeAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Molecular "omic" signatures in systemic sclerosis.European journal of rheumatology · 2020
    Review
  5. Article
  6. Pathogenesis of systemic sclerosis associated interstitial lung disease.Journal of scleroderma and related disorders · 2020
    Article
  7. Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors at 20 institutions in 1 country.

Pravitt GourhNIAMS and National Human Genome Research Institute, NIH, Bethesda, Maryland.ORCID 0000-0002-6488-1850
Elaine F RemmersNational Human Genome Research Institute, NIH, Bethesda, Maryland.ORCID 0000-0002-9522-1249
Steven E BoydenNational Human Genome Research Institute, NIH, Bethesda, Maryland.
Theresa AlexanderNIAMS, NIH, Bethesda, Maryland.
Nadia D MorganJohns Hopkins University School of Medicine, Baltimore, Maryland.
Ami A ShahJohns Hopkins University School of Medicine, Baltimore, Maryland.ORCID 0000-0002-1139-2009
Maureen D MayesUniversity of Texas McGovern Medical School, Houston.
Ayo DoumateyNational Human Genome Research Institute, NIH, Bethesda, Maryland.
Amy R BentleyNational Human Genome Research Institute, NIH, Bethesda, Maryland.
Daniel ShrinerNational Human Genome Research Institute, NIH, Bethesda, Maryland.
Robyn T DomsicUniversity of Pittsburgh, Pittsburgh, Pennsylvania.
Thomas A MedsgerUniversity of Pittsburgh, Pittsburgh, Pennsylvania.
Virginia D SteenGeorgetown University School of Medicine, Washington, DC.
Paula S RamosMedical University of South Carolina, Charleston.
Richard M SilverMedical University of South Carolina, Charleston.
Benjamin KormanNorthwestern University, Feinberg School of Medicine, Chicago, Illinois.
John VargaNorthwestern University, Feinberg School of Medicine, Chicago, Illinois.
Elena SchiopuUniversity of Michigan, Ann Arbor.
Dinesh KhannaUniversity of Michigan, Ann Arbor.
Vivien HsuRobert Wood Johnson University, New Brunswick, New Jersey.
Jessica K GordonHospital for Special Surgery, New York, New York.ORCID 0000-0001-8068-0592
Lesley Ann SaketkooTulane University School of Medicine, New Orleans, Louisiana.
Heather GladueArthritis and Osteoporosis Consultants of the Carolinas, Charlotte, North Carolina.
Brynn KronUniversity of California, San Francisco.
Lindsey A CriswellUniversity of California, San Francisco.
Chris T DerkUniversity of Pennsylvania, Philadelphia.
S Louis BridgesUniversity of Alabama at Birmingham.ORCID 0000-0003-3785-1389
Victoria K ShanmugamThe George Washington University, Washington, DC.
Kathleen D KolstadStanford University School of Medicine, Stanford, California.
Lorinda ChungStanford University School of Medicine, Stanford, California, and Palo Alto VA Health Care System, Palo Alto, California.
Reem JanUniversity of Chicago, Pritzker School of Medicine, Chicago, Illinois.
Elana J BernsteinNew York Presbyterian Hospital, Columbia University, New York, New York.ORCID 0000-0001-5560-6390
Avram GoldbergNew York University Langone Medical Center, New York, New York.
Marcin TrojanowskiBoston University School of Medicine, Boston, Massachusetts.
Suzanne KafajaDavid Geffen School of Medicine, University of California, Los Angeles.
Kathleen M Maksimowicz-McKinnonHenry Ford Health System, Detroit, Michigan.
James C MullikinNational Human Genome Research Institute, NIH Intramural Sequencing Center, Rockville, Maryland.
Adebowale AdeyemoNational Human Genome Research Institute, NIH, Bethesda, Maryland.
Charles RotimiNational Human Genome Research Institute, NIH, Bethesda, Maryland.
Francesco BoinUniversity of California, San Francisco.
Daniel L KastnerNational Human Genome Research Institute, NIH, Bethesda, Maryland.
Fredrick M WigleyJohns Hopkins University School of Medicine, Baltimore, Maryland.
National Human Genome Research Institute · USJohns Hopkins University · USUniversity of California, San Francisco · USMedical University of South Carolina · USNorthwestern University · USUniversity of Michigan · USUniversity of Pittsburgh · USBoston University · USGeorgetown University · USGeorge Washington University · USHenry Ford Health System · USHospital for Special Surgery · USJohnson University · USNational Institute of Arthritis and Musculoskeletal and Skin Diseases · USNewYork–Presbyterian Hospital · USNYU Langone Health · USStanford University · USTulane University · USUniversity of Alabama at Birmingham · USUniversity of California, Los Angeles · US

Funding

Inter- and Intra-Species Comparative SequencingZIBHG000196 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI THOMAS, JAMES · 2009 to 2025
$177.6M
Genetic epidemiology of complex diseasesZIAHG200362 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI ROTIMI, CHARLES · 2009 to 2025
$54.7M
Genetic Analysis of Complex Inflammatory DisordersZIAHG200371 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI KASTNER, DANIEL · 2011 to 2024
$18.8M
Center for Clinical and Translational Sciences (CCTS)UL1TR000371 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2012 to 2016
$13.4M
SOUTH CAROLINA CLINICAL & TRANSLATIONAL RESEARCH INSTITUTE (SCTR)UL1RR029882 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2009 to 2011
$10.1M
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR000062 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2012 to 2014
$9.4M
RESOURCE-BASED CENTER FOR THE ADVANCEMENT OF PRECISION MEDICINE IN RHEUMATOLOGYP30AR070155 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Mary C Nakamura · 2016 to 2026
$8.2M
Role of TGF-beta and CTGF Signaling Transgenic Mouse Models of SclerodermaP50AR054144 · NIAMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MAYES, MAUREEN MAUREEN · 2006 to 2010
$7.7M
Training Program in Adult and Pediatric RheumatologyT32AR050942 · NIAMS · STANFORD UNIVERSITY · PI LEWIS, DAVID BRAM, ROBINSON, WILLIAM H · 2005 to 2025
$6.6M
Multidisciplinary Rheumatology Training ProgramT32AR048522 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI CLIFTON O BINGHAM, LIVIA A CASCIOLA-ROSEN · 2003 to 2026
$6.4M
Genetics and Pathogenesis of SclerodermaZIAAR041209 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI GOURH, PRAVITT · 2019 to 2024
$6.3M
Two-Stage Genome-Wide Association Study in Systemic SclerosisR01AR055258 · NIAMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MAYES, MAUREEN MAUREEN · 2008 to 2012
$5.9M
Intramural NIH HHS Z99 AR999999Intramural NIH HHS ZIA HG200371NCATS NIH HHS UL1-TR-000062NCATS NIH HHS UL1 TR000371NCRR NIH HHS UL1 RR029882NCRR NIH HHS UL1-RR-029882NIAMS NIH HHS K01 AR067280NIAMS NIH HHS K01-AR-067280NIAMS NIH HHS K23 AR061439NIAMS NIH HHS K23-AR-061439NIAMS NIH HHS K24 AR063120NIAMS NIH HHS K24-AR-063120NIAMS NIH HHS N01 AR002251NIAMS NIH HHS N01-AR-02251NIAMS NIH HHS P30 AR070155NIAMS NIH HHS P50 AR054144NIAMS NIH HHS P50-AR-054144NIAMS NIH HHS P60 AR062755NIAMS NIH HHS P60-AR-062755NIAMS NIH HHS R01 AR055258NIAMS NIH HHS R01-AR-055258NIAMS NIH HHS R03 AR065801NIAMS NIH HHS R03-AR-065801NIAMS NIH HHS T32-AR-048522NIAMS NIH HHS T32 AR050942NINR NIH HHS R01 NR013888NINR NIH HHS R01-NR-013888
6 · The paper itself

Abstract

objectiveWhole-exome sequencing (WES) studies in systemic sclerosis (SSc) patients of European American (EA) ancestry have identified variants in the ATP8B4 gene and enrichment of variants in genes in the extracellular matrix (ECM)-related pathway that increase SSc susceptibility. This study was undertaken to evaluate the association of the ATP8B4 gene and the ECM-related pathway with SSc in a cohort of African American (AA) patients.

methodsSSc patients of AA ancestry were enrolled from 23 academic centers across the US under the Genome Research in African American Scleroderma Patients consortium. Unrelated AA individuals without serologic evidence of autoimmunity who were enrolled in the Howard University Family Study were used as unaffected controls. Functional variants in genes reported in the 2 WES studies in EA patients with SSc were selected for gene association testing using the optimized sequence kernel association test (SKAT-O) and pathway analysis by Ingenuity Pathway Analysis in 379 patients and 411 controls.

resultsPrincipal components analysis demonstrated that the patients and controls had similar ancestral backgrounds, with roughly equal proportions of mean European admixture. Using SKAT-O, we examined the association of individual genes that were previously reported in EA patients and none remained significant, including ATP8B4 (P = 0.98). However, we confirmed the previously reported association of the ECM-related pathway with enrichment of variants within the COL13A1, COL18A1, COL22A1, COL4A3, COL4A4, COL5A2, PROK1, and SERPINE1 genes (corrected P = 1.95 × 10

conclusionIn the largest genetic study in AA patients with SSc to date, our findings corroborate the role of functional variants that aggregate in a fibrotic pathway and increase SSc susceptibility.

Indexed as

Adenosine TriphosphatasesAdultBlack or African AmericanExome SequencingExtracellular Matrix ProteinsFemaleGene Regulatory NetworksGenetic Predisposition to DiseaseGenetic VariationHumansMaleMiddle AgedPrincipal Component AnalysisScleroderma, SystemicWhite PeopleAdenosine TriphosphatasesATP8B4 protein, humanExtracellular Matrix Proteins

Identifiers

PMID29732714
PMCPMC6160338
OpenAlexW2802159764

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.